Type 2 Diabetes

2 studies

2 studies

Observational
Full Text
Are tirzepatide and semaglutide equally effective for heart health in diabetes patients?
Tirzepatide and semaglutide showed comparable cardiovascular benefits in diabetes patients, with both reducing heart attacks and strokes.
Nature Medicine·2025-11-09
Clinical Trial
Abstract
Does oral semaglutide reduce heart attacks and strokes in high-risk diabetes patients?
Oral semaglutide reduced major heart and vascular events in people with type 2 diabetes and high cardiovascular risk without increasing serious side effects.
New England Journal of Medicine·2025-03-29